Categories: FAANG

Cardiac Clarity: Dr. Keith Channon Talks Revolutionizing Heart Health With AI

Here’s some news to still beating hearts: AI is helping bring some clarity to cardiology. Caristo Diagnostics has developed an AI-powered solution for detecting coronary inflammation in cardiac CT scans. In this episode of NVIDIA’s AI Podcast, Dr. Keith Channon, the Field Marshal Earl Alexander Professor at the University of Oxford, and the cofounder and chief medical officer at the startup, speaks with host Noah Kravtiz about the technology. Called Caristo, it analyzes radiometric features in CT scan data to identify inflammation in the fat tissue surrounding coronary arteries, a key indicator of heart disease. Tune in to learn more about how Caristo uses AI to improve treatment plans and risk predictions by providing physicians with a patient-specific readout of inflammation levels.

Show Notes

1:56: What is ‌Caristo and how does it work?
7:11 The key signal of a heart attack
10:34 How did Channon come up with the idea of using AI to drive breakthroughs?
22:40 How much has the CT scan changed over the years?
26:01: What’s ahead for Caristo?
30:14: How to take care of your own heart health

You Might Also Like

Immunai Uses Deep Learning to Develop New Drugs – Ep. 176
What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company using AI technology to map the human immune system and speed the development of new immunotherapies against cancer and autoimmune diseases.

Overjet on Bringing AI to Dentistry – Ep. 179
Dentists get a bad rap. Dentists also get more people out of more aggravating pain than just about anyone, which is why the more technology dentists have, the better. Overjet, a member of the NVIDIA Inception program for startups, is moving fast to bring AI to dentists’ offices.

Democratizing Drug Discovery With Deep Learning – Ep. 172
It may seem intuitive that AI and deep learning can speed up workflows — including novel drug discovery, a typically years-long and several-billion-dollar endeavor. But, professors Artem Cherkasov and Olexandr Isayev were surprised that no recent academic papers provided a comprehensive, global research review of how deep learning and GPU-accelerated computing impact drug discovery.

Subscribe to the AI Podcast

Get the AI Podcast through iTunes, Google Podcasts, Google Play, Amazon Music, Castbox, DoggCatcher, Overcast, PlayerFM, Pocket Casts, Podbay, PodBean, PodCruncher, PodKicker, Soundcloud, Spotify, Stitcher and TuneIn.

Make the AI Podcast better: Have a few minutes to spare? Fill out this listener survey.

AI Generated Robotic Content

Recent Posts

Using Amazon Q Business with AWS HealthScribe to gain insights from patient consultations

With the advent of generative AI and machine learning, new opportunities for enhancement became available…

2 hours ago

How a 12-Ounce Layer of Foam Changed the NFL

Even the makers of the Guardian Cap admit it looks silly. But for a sport…

3 hours ago

Combining next-token prediction and video diffusion in computer vision and robotics

In the current AI zeitgeist, sequence models have skyrocketed in popularity for their ability to…

3 hours ago

What Is Perplexity AI? Understanding One Of Google’s Biggest Search Engine Competitors

What is Perplexity AI? Is it an over-hyped replacement for Google as a search engine,…

1 day ago

Scalable Private Search with Wally

This paper presents Wally, a private search system that supports efficient semantic and keyword search…

1 day ago

How DPG Media uses Amazon Bedrock and Amazon Transcribe to enhance video metadata with AI-powered pipelines

This post was co-written with Lucas Desard, Tom Lauwers, and Sam Landuydt from DPG Media.…

1 day ago